Skip to main content
. Author manuscript; available in PMC: 2017 May 15.
Published in final edited form as: Cancer. 2016 Mar 29;122(10):1608–1617. doi: 10.1002/cncr.29946

Table 1. Sample characteristics.

Participants
T12
(n=159)
Participants
T42
(n=96)
Missing
T42
(n=64)
P-value
Age at diagnosis, n(%) 1.000
 Pre-school (ages 2-4) 86 (54.1%) 52 (54.17%) 35 (54.69%)
 School-age (ages 5-9) 73 (45.9%) 44 (45.83%) 29 (45.31%)

Sex, n(%) <0.01
 Female 76 (47.8%) 59 (61.46%) 18 (28.13%)
 Male 83 (52.2%) 37 (38.54%) 46 (71.88%)

Child ethnicity, n(%) 0.75
 White, non-Hispanic 108 (67.9%) 65 (67.71%) 43 (67.19%)
 Black, non-Hispanic 11 (6.9%) 5 (5.21%) 6 (9.38%)
 Hispanic 26 (16.4%) 17 (17.71%) 10 (15.63%)
 Other 14 (8.8%) 9 (9.38%) 5 (7.81%)

Marital status, n(%) 0.40
 Married 105 (66.0%) 77 (80.21%) 44 (68.75%)
 Not Married 45 (28.3%) 16 (16.67%) 14 (21.88%)
Missing 9 (5.7%) 3 (3.12%) 6 (9.4%)

Treatment randomization, n(%) 0.23
 Standard CS/standard IM-DI1 42 (26.42%) 26 (27.08%) 17 (26.56%)
 Intensified CS/standard IM-DI1 51 (32.08%) 26 (27.08%) 25 (39.06%)
 Standard CS/augmented IM-DI1 37 (23.27%) 27 (28.13%) 10 (15.63%)
 Intensified CS/augmented IM-DI1 29 (18.24%) 17 (17.71%) 12 (18.75%)
1

CS=Consolidation, IM=Interim Maintenance, DI=Delayed Intensification

2

T1=start of consolidation, T4=3 months after completion of therapy

*

p-value denotes exact chi-squared test comparison between T4 participants and missing T4 data